SIR GANGA RAM HOSPITAL

Indian scientists developed Nafithromycin, an indigenous antibiotic targeting Community-Acquired Bacterial Pneumonia (CABP), crucial in combating antimicrobial resistance (AMR). Marketed as 'Miqnaf', it treats drug-resistant bacteria, particularly affecting vulnerable populations. Nafithromycin, 10 times more effective than current treatments, offers a three-day regimen, improving patient compliance and safety. Experts emphasize the need for rational antibiotic use to prevent resistance.

The Undiagnosed Hackathon was conceptualized and designed by H.C., M. Cederroth, A.N., and A.M.D.V. Biological samples and phenotype data were collected by various authors, processed and analyzed under the coordination of A.M.D.V. et al. All authors participated in data analysis and interpretation, with A.M.D.V. et al. drafting the manuscript. A.N., H.C., and M. Cederroth secured funding.

Kiran Mazumdar-Shaw, Biocon's Executive Chairperson, awarded Honorary Doctor of Science by Concordia University for her leadership in biotechnology and affordable healthcare.